|
You are here |
kellblog.com | ||
| | | | |
bootstraplabs.com
|
|
| | | | | [AI summary] A panel discussion from the BootstrapLabs Applied AI Conference 2018 explores the role of AI in finance technology, emphasizing interpretability, data privacy, regulatory relationships, and case studies from industry leaders. | |
| | | | |
www.paulgraham.com
|
|
| | | | | [AI summary] This essay argues that the most effective startup strategy is to focus on creating something users love with sincere benevolence rather than worrying about profitability early on, citing examples like Google and Craigslist. | |
| | | | |
biosimilarsrr.com
|
|
| | | | | It's been a busy couple of weeks, and we're taking this time to catch up on some specific biosimilar product news. Samsung Bioepis and Teva Launches Their Eculizumab Biosimilar The biosimilar maker Samsung Bioepis and its marketing partner Teva Pharmaceuticals announced on April 7 that it had launched Epysqli in the United States. This is ... Continue reading Biosimilar Bytes: Eculizumab Biosimilar Launches, Rights to Actemra Biosimilar Sold, and New Biosimilar Bevacizumab Approved | |
| | | | |
gizmodo.com
|
|
| | | Anthropic's skyrocketing valuation underscores how investor appetite for AI overrides the traditional risk calculus. | ||